Literature DB >> 17362679

Stroke and migraine.

Jesse Weinberger1.   

Abstract

Young patients with migraine are at increased risk for stroke, particularly patients with an aura of focal neurologic deficits. Other causes of ischemia are often identified in patients with migraine, including patent foramen ovale, lupus anticoagulant, cervical carotid dissection, arteriovenous malformation, and hyperactivity of the clotting system. Migrainous stroke is only diagnosed when all other possible causes of stroke have been eliminated and the patient has irreversibility of the usual aura, associated with an ischemic infarct in the appropriate brain territory. Prophylactic therapy of migraine with aura may be beneficial in preventing migrainous stroke.

Entities:  

Mesh:

Year:  2007        PMID: 17362679     DOI: 10.1007/s11886-007-0004-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  64 in total

1.  History of migraine and the risk of spontaneous cervical artery dissection.

Authors:  A Pezzini; F Granella; M Grassi; C Bertolino; E Del Zotto; P Immovilli; E Bazzoli; A Padovani; C Zanferrari
Journal:  Cephalalgia       Date:  2005-08       Impact factor: 6.292

2.  The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel.

Authors:  A Ducros; C Denier; A Joutel; M Cecillon; C Lescoat; K Vahedi; F Darcel; E Vicaut; M G Bousser; E Tournier-Lasserve
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

Review 3.  Oral contraceptives and stroke.

Authors:  M G Bousser; S J Kittner
Journal:  Cephalalgia       Date:  2000-04       Impact factor: 6.292

4.  Brief therapeutic report: papaverine prophylaxis of complicated migraine.

Authors:  N Vijayan
Journal:  Headache       Date:  1977-09       Impact factor: 5.887

5.  Prevalence and size of directly detected patent foramen ovale in migraine with aura.

Authors:  M Schwerzmann; K Nedeltchev; F Lagger; H P Mattle; S Windecker; B Meier; C Seiler
Journal:  Neurology       Date:  2005-09-07       Impact factor: 9.910

Review 6.  Topiramate in migraine prophylaxis.

Authors:  D D'Amico; L Grazzi; S Usai; F Moschiano; G Bussone
Journal:  Neurol Sci       Date:  2005-05       Impact factor: 3.307

7.  C-reactive protein may be increased in migraine patients who present with complex clinical features.

Authors:  K M A Welch; Avery W Brandes; Lauren Salerno; Jan Lewis Brandes
Journal:  Headache       Date:  2006-02       Impact factor: 5.887

8.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine.

Authors:  Jes Olesen; Hans-Christoph Diener; Ingo W Husstedt; Peter J Goadsby; David Hall; Ulrich Meier; Stephane Pollentier; Lynna M Lesko
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

9.  An epidemiological survey of hemiplegic migraine.

Authors:  L Lykke Thomsen; M Kirchmann Eriksen; S Faerch Romer; I Andersen; E Ostergaard; N Keiding; J Olesen; M B Russell
Journal:  Cephalalgia       Date:  2002-06       Impact factor: 6.292

10.  Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine.

Authors:  J Olesen; B Larsen; M Lauritzen
Journal:  Ann Neurol       Date:  1981-04       Impact factor: 10.422

View more
  2 in total

1.  Migraine responsive to warfarin: an update on anticoagulant possible role in migraine prophylaxis.

Authors:  F Maggioni; M Bruno; F Mainardi; C Lisotto; G Zanchin
Journal:  Neurol Sci       Date:  2012-01-06       Impact factor: 3.307

2.  An unusual case report on the possible role of Warfarin in migraine prophylaxis.

Authors:  Angelo Russo; Sara Santi; Daniela Gueraldi; Maria De Paola; Fabiana Zani; Luigi Alberto Pini
Journal:  Springerplus       Date:  2013-02-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.